Topical anti-inflammatory drug therapy

Details Topical anti-inflammatory drug therapy Topical anti-inflammatory drug therapy

A - Human Necessities

61

K

167/159, 167/196

A61K 31/38 (2006.01) A61K 31/56 (2006.01) A61K 31/57 (2006.01) A61K 31/58 (2006.01) A61K 31/60 (2006.01) A61K 47/10 (2006.01) A61K 47/20 (2006.01)

Patent

CA 1101334

ABSTRACT OF THE DISCLOSURE A pharmaceutical composition for topical treatment of cutameous disorders or disruptions characterized by skin inflammation or hyperproliferative epidermal activity comprises the combination of a topically active anti-inflammatory corticosteroid and a non-steroidal anti-inflammatory agent which is an inhibitor of prostaglandin synthetase selected from the group consisting of the hydratropic acid derivations; acetylsalicylic acid; the pyrazolonedericativen; the fenamic acid derivatives; the aroyl-substituted pyrroles and the substituted arylacetohydroxamic acids in a pharmaceutically acceptiable topical vehicle. Treatment of above cutaneous disorders may also be effected by concurrent therapy using separate applications of corticosteriod and non-steroid.

277688

Affiliated with

Also associated with

Rating

Topical anti-inflammatory drug therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Topical anti-inflammatory drug therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topical anti-inflammatory drug therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-79485